21h
Zacks.com on MSN10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseGenomics (TXG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EST Cathie Wood’s ARK Investment buys 77.6K shares of 10x Genomics (TXG) todayMaximize Your Portfolio with Data Driven Insights:Leverage ...
February 05, 2025, 03:25 AM ET, BY Thomas H. Kee Jr, Editor, Stock Traders Daily | Editor: Derek Curry ( Follow on LinkedIn ) ...
Construction substantially complete and first copper concentrate on track for March (All amounts expressed in U.S. dollars ...
James reiterated its Outperform rating and Cdn$34.00 price target for Torex Gold Resources (TXG:CN) (OTC: OTC:TORXF). The firm's analyst highlighted the company's significant progress on its Media ...
In a report released today, Michael Ryskin from Bank of America Securities maintained a Hold rating on 10x Genomics (TXG – Research Report).
View 10x Genomics, Inc. (TXG) current and estimated P/E ratio data provided by Seeking Alpha.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results